Here's Why Zimmer Biomet ( ZBH ) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Looking Into Zimmer Biomet Holdings's Recent Short Interest - Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet Holdings's ZBH short percent of float has fallen 19.29% since its last report. The company recently reported that it has 5.93 million shares sold short, which is 3.43% of all regular shares that are available for trading.
NeuroOne Q3 Revenue Jumps 105 Percent
NeuroOne Medical Technologies ( NASDAQ:NMTC ) reported fiscal third quarter 2025 earnings on August 14, 2025, with product revenue up 105% year-over-year to $1.7 million and product gross margins rising to 53.9% from 34.1% in the third quarter of fiscal year 2024.
NeuroOne ( NMTC ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, Aug. 14, 2025 at 8:30 a.m. ETChief Executive Officer - David A. RosaContinue reading ...
NeuroOne Revenue Jumps 105 Percent in Q3
NeuroOne Medical Technologies ( NASDAQ:NMTC ) , a med-tech company specializing in advanced thin film electrode and ablation systems for neurological disorders, reported Q3 FY2025 results on August 14, 2025. The earnings release showcased a material improvement in profitability, with earnings per ...
Why Zimmer Biomet ( ZBH ) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story
Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Dip into a beaten-down market sector for deals on some proven winners.
Zimmer Biomet Flexes Strong Q2, Raises 2025 Outlook - Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet Q2 EPS rises 3% to $2.07, beating the $1.99 estimate; sales reaches $2.08 billion, topping the consensus. 2025 EPS guidance raises to $8.10-$8.30 vs. $7.90-$8.10 prior; revenue growth forecast narrows to 6.7%-7.7% The market's back, and these 3 income stocks are thriving.
ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up
Zimmer Biomet gains as Q2 earnings and revenues top estimates. full-year EPS guidance raised on strong segment growth.
Zimmer Biomet ( ZBH ) Q2 Revenue Jumps 7%
Zimmer Biomet ( NYSE:ZBH ) , an orthopedic medical technology company, reported its earnings on August 7, 2025. The company announced GAAP revenue of $2.077 billion, beating analyst estimates of $2.057 billion. Adjusted earnings per share ( EPS ) , a profitability metric that excludes certain ...
Zimmer Biomet ( ZBH ) Beats Q2 Earnings and Revenue Estimates
Zimmer (ZBH) delivered earnings and revenue surprises of +4.55% and +1.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for Zimmer ( ZBH ) Q2 Earnings, Beyond Revenue and EPS
Get a deeper insight into the potential performance of Zimmer (ZBH) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Zimmer Biomet to Report Q2 Earnings: Here's What to Expect
ZBH's Q2 results may show strength in Hips, Knees, and S.E.T. despite a projected year-over-year earnings dip.
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
SUNNYVALE, Calif., Aug. 04, 2025 ( GLOBE NEWSWIRE ) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today provides the anticipated timing of regulatory activities seeking FDA and Japan PMDA ...
Will Canopy Growth Corporation ( CGC ) Report Negative Earnings Next Week? What You Should Know
Canopy Growth (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Zimmer Biomet ( ZBH ) to Report a Decline in Earnings: What to Look Out for
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Monogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery
The Procedure Utilized Monogram's mBôs TKA System Performed in India with Shalby Hospitals Groundbreaking Procedure Delivers the World's First Autonomous Saw-Based Robotic TKA Surgery on a Live Patient
What Does the Market Think About Zimmer Biomet Holdings? - Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet Holdings's ZBH short percent of float has fallen 13.09% since its last report. The company recently reported that it has 7.34 million shares sold short, which is 4.25% of all regular shares that are available for trading.
Can ISRG's Strong Q2 Procedure Volume Translate Into Durable EPS Upside?
ISRG's Q2 procedure growth hits 17%, but continuation of EPS growth hinges on easing margin pressure from FX and da Vinci 5 adoption.
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
PALM BEACH GARDENS, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- ZimVie Inc. ( Nasdaq: ZIMV ) , a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on ...
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 - ZimVie ( NASDAQ:ZIMV )
PALM BEACH GARDENS, Fla., July 25, 2025 ( GLOBE NEWSWIRE ) -- ZimVie Inc. ZIMV, a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July ...
P/E Ratio Insights for Zimmer Biomet Holdings - Zimmer Biomet Holdings ( NYSE:ZBH )
Looking into the current session, Zimmer Biomet Holdings Inc. ZBH shares are trading at $97.99, after a 1.52% increase. Moreover, over the past month, the stock increased by 5.16%, but in the past year, fell by 12.03%.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SONN, FCCO, MGRM on Behalf of Shareholders - Monogram Technologies ( NASDAQ:MGRM ) , First Community ( NASDAQ:FCCO )
NEW YORK, July 19, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Sonnet BioTherapeutics, Inc.
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal
Zimmer Biomet eyes long-term gains with the $177M Monogram buyout, aiming to expand its robotic knee surgery offerings by 2027.
4 Mid-Cap Value Mutual Funds for Long-Term Gains
VASVX, TAMVX, TRVPX and FVLKX offer mid-cap value exposure with solid returns, low fees, and long-term growth potential.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WAT, VBTX, MGRM on Behalf of Shareholders - Monogram Technologies ( NASDAQ:MGRM ) , Veritex Holdings ( NASDAQ:VBTX )
NEW YORK, July 16, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VRNA, KLG, MRGM, SONN on Behalf of Shareholders - Monogram Technologies ( NASDAQ:MGRM ) , WK Kellogg ( NYSE:KLG )
NEW YORK, July 14, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Monogram Technologies Inc. ( NASDAQ: MGRM )
NEW YORK, July 14, 2025 ( GLOBE NEWSWIRE ) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC ( the "M&A Class Action Firm" ) , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, VBTX on Behalf of Shareholders - Monogram Technologies ( NASDAQ:MGRM ) , Veritex Holdings ( NASDAQ:VBTX )
NEW YORK, July 14, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Monogram Technologies Inc.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. ( Nasdaq - MGRM ) , Veritex Holdings, Inc. ( Nasdaq - VBTX ) , ESSA Pharma Inc. ( Nasdaq - EPIX ) , Waters Corporation ( NYSE - WAT ) - Huntington Bancshares ( NASDAQ:HBAN )
BALA CYNWYD, Pa., July 14, 2025 ( GLOBE NEWSWIRE ) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ( [email protected] ) or Marc Ackerman ( [email protected] ) at 855-576-4847.
MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet - Monogram Technologies ( NASDAQ:MGRM )
MONSEY, N.Y., July 14, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc.
Zimmer Biomet Bets Big On Robotic Future With Monogram Deal - Monogram Technologies ( NASDAQ:MGRM ) , Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet to acquire Monogram for $4.04/share upfront, with potential CVR payout up to $12.37/share by 2030. Monogram's AI-assisted robotic knee system got FDA clearance in March 2025, launch expected in 2027.
Boeing, Uber, Delta And A Health Care Stock On CNBC's 'Final Trades' - Delta Air Lines ( NYSE:DAL ) , Boeing ( NYSE:BA )
Stephanie Link names Boeing as her final trade. Joshua Brown picks Uber as his final trade. PPI and Industrial Production drop Wednesday morning - see how Matt Maley is trading the reaction, live at 6 PM ET.
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions - Monogram Technologies ( NASDAQ:MGRM )
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings per share in 2025 - 2027 and accretive thereafter and to contribute to revenue growth beginning in ...
Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings per share in 2025 - 2027 and accretive thereafter and to contribute to revenue growth beginning in ...
New PatentVest Pulse Report Maps the Competitive and IP Landscape of the $188B Surgical Robotics Market
Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of the most underpenetrated markets in medtech Designed for investors, board members, and CEOs, the latest PatentVest Pulse reveals who's actually leading and why in one of ...
Peering Into Zimmer Biomet Holdings's Recent Short Interest - Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet Holdings's ZBH short percent of float has risen 16.61% since its last report. The company recently reported that it has 6.42 million shares sold short, which is 3.72% of all regular shares that are available for trading.
ISRG Margin Outlook Dips on Tariffs, Demand Signals Stay Strong
Intuitive Surgical trims margin outlook on tariff headwinds, but strong procedure growth and financial resilience bolster its long-term case.
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology
PONTE VEDRA, Fla., June 05, 2025 ( GLOBE NEWSWIRE ) -- Treace Medical Concepts, Inc. ( "Treace" or the "Company" ) ( NasdaqGS: TMCI ) , a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® ...
Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology - Zimmer Biomet Holdings ( NYSE:ZBH ) , Treace Medical Concepts ( NASDAQ:TMCI )
PONTE VEDRA, Fla., June 05, 2025 ( GLOBE NEWSWIRE ) -- Treace Medical Concepts, Inc. ( "Treace" or the "Company" ) TMCI, a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and ...
Why Is Zimmer ( ZBH ) Down 0.5% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors - Neurocrine Biosciences ( NASDAQ:NBIX ) , Fate Therapeutics ( NASDAQ:FATE )
SAN DIEGO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Fate Therapeutics, Inc. FATE, a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell ( iPSC ) -derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Matthew ...
Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors
SAN DIEGO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Fate Therapeutics, Inc. ( NASDAQ: FATE ) , a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell ( iPSC ) -derived off-the-shelf cellular immunotherapies to patients, today announced the ...
Sternal Closure Systems Market Size to Grow USD 6.32 Billion by 2031 with 6.1% CAGR, Advancements in Surgical Techniques and Rising Incidence of Cardiovascular Diseases Fuel | The Insight Partners
US & Canada, May 28, 2025 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the sternal closure systems market is witnessing significant growth owing to the advancements in surgical techniques and the rising incidence of cardiovascular diseases ( CVDs ) .
ZBH Stock to Gain From Buyouts and Innovations Amid Macro Issues
Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%
Filed 510 ( k ) Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule ...
Should VanEck Morningstar Wide Moat ETF ( MOAT ) Be on Your Investing Radar?
Style Box ETF report for MOAT ...
These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Zimmer Biomet Holdings ( NYSE:ZBH )
Zimmer Biomet Holdings, Inc ZBH reported better-than-expected earnings for the first quarter on Monday. The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, beating the Street estimates of $1.77.
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies are set to report earnings on May 7, stay tuned!
